Remifentanil
In the US, Remifentanil (remifentanil systemic) is a member of the drug class narcotic analgesics and is used to treat Anesthesia.
US matches:
UK matches:
- REMIFENTANIL 1 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION (Leaflet)
- REMIFENTANIL 1 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION/INFUSION (Leaflet)
- REMIFENTANIL 1 MG POWDER FOR CONCENTRATION FOR SOLUTION FOR INJECTION OR INFUSION (Leaflet)
- REMIFENTANIL 1MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION (Leaflet)
- REMIFENTANIL 2 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION (Leaflet)
- REMIFENTANIL 2 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION/INFUSION (Leaflet)
- REMIFENTANIL 2MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION (Leaflet)
- REMIFENTANIL 5 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION (Leaflet)
- REMIFENTANIL 5 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION/INFUSION (Leaflet)
- REMIFENTANIL 5MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N01AH06
CAS registry number (Chemical Abstracts Service)
0132875-61-7
Chemical Formula
C20-H28-N2-O5
Molecular Weight
376
Therapeutic Categories
Anesthetic, injectable
Opioid analgesic
Chemical Name
1-Piperidinepropanoic acid, 4-(methoxycarbonyl)-4-[(1-oxopropyl)phenylamino]-, methyl ester
Foreign Names
- Remifentanilum (Latin)
- Remifentanil (German)
- Remifentanil (French)
- Remifentanilo (Spanish)
Generic Names
- Remifentanil (OS: BAN)
- GI 87084 X (IS: GlaxoWellcome)
- Remifentanil Hydrochloride (OS: USAN, BANM)
- GI 87084 B (IS: Glaxo)
Brand Names
- Ulremif
Teva, Bulgaria - Ultiva
GlaxoSmithKline, Tunisia; GlaxoSmithKline, South Africa - Remifentanil Actavis
Actavis, Switzerland; Actavis, Estonia; Actavis, Norway; Actavis, Sweden - Rémifentanil Actavis
Actavis, France - Remifentanil Chiesi
Chiesi, Estonia - Remifentanil Fresenius
Fresenius, Switzerland - Remifentanil Fresenius Kabi
Fresenius Kabi, Sweden - Remifentanil Hospira
Hospira, Estonia; Hospira, United Kingdom - Remifentanil Kabi
Fresenius Kabi, Estonia; Fresenius Kabi, Latvia - Rémifentanil Kabi
Fresenius Kabi, France - Rémifentanil Mylan
Mylan, France - Remifentanil Orion
Orion, Switzerland; Orion, Norway - Remifentanil Sandoz
Sandoz, Switzerland - Remifentanil Teva
Teva, Sweden - Rémifentanil Teva
Teva Santé, France - Remifentanil Torrex
Torrex Chiesi, Bulgaria - Remifentanil
Fresenius, Malta - Remifentanil-Teva
Teva Pharma, Switzerland - Rui Jie
Renfu Pharmaceutical, China - Ultiva
Abbott, Canada; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Argentina; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Barbados; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Egypt; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Grenada; GlaxoSmithKline, Greece; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Israel; GlaxoSmithKline, Iraq; GlaxoSmithKline, Iran; GlaxoSmithKline, Italy; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Jordan; GlaxoSmithKline, South Korea; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Lebanon; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Malta; GlaxoSmithKline, Mexico; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Peru; GlaxoSmithKline, Poland; GlaxoSmithKline, Portugal; GlaxoSmithKline, Qatar; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Saudi Arabia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Syria; GlaxoSmithKline, Turkey; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, Venezuela; GlaxoSmithKline, Yemen; Janssen Pharmaceutical K.K., Japan; Mylan, United States
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
